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The formation of cartilage elements in the developing vertebrate limb, where they serve as primordia for the appendicular
skeleton, is preceded by the appearance of discrete cellular condensations. Control of the size and spacing of these
condensations is a key aspect of skeletal pattern formation. Limb bud cell cultures grown in the absence of ectoderm formed
continuous sheet-like masses of cartilage. With the inclusion of ectoderm, these cultures produced one or more cartilage
nodules surrounded by zones of noncartilaginous mesenchyme. Ectodermal fibroblast growth factors (FGF2 and FGF8), but
not a mesodermal FGF (FGF7), substituted for ectoderm in inhibiting chondrogenic gene expression, with some
combinations of the two ectodermal factors leading to well-spaced cartilage nodules of relatively uniform size. Treatment
of cultures with SU5402, an inhibitor FGF receptor tyrosine kinase activity, rendered FGFs ineffective in inducing
perinodular inhibition. Inhibition of production of FGF receptor 2 (FGFR2) by transfection of wing and leg cell cultures with
antisense oligodeoxynucleotides blocked appearance of ectoderm- or FGF-induced zones of perinodular inhibition of
chondrogenesis and, when introduced into the limb buds of developing embryos, led to shorter, thicker, and fused cartilage
elements. Because FGFR2 is expressed mainly at sites of precartilage condensation during limb development in vivo and in
vitro, these results suggest that activation of FGFR2 by FGFs during development elicits a lateral inhibitor of chondrogen-
esis that limits the expansion of developing skeletal elements. © 2002 Elsevier Science (USA)
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The formation of cartilage elements both in the develop-
ing vertebrate limb, where they serve as primordia for the
appendicular skeleton, and in high-density cultures of limb
bud mesenchyme, a well-studied in vitro model for this
process, is preceded by discrete cellular condensations (Hall
and Miyake, 1995, 2000; Newman and Tomasek, 1996).
Control of the size and spacing of these condensations is a
key aspect of skeletal pattern formation. In particular, the
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270tandem and parallel arrangements of individual elements
that characterize all vertebrate limbs depend on most
precartilage condensations remaining discrete, although
fusion of certain condensations also plays an important part
in limb development in some species (Shubin, 1991). Cul-
tures of chicken precartilage mesenchyme can be used to
study both modes of condensation development. When
grown in a serum-free medium, wing bud cells obtained
from Hamburger–Hamilton stages 24–26 embryos form
condensations that expand and eventually fuse, differenti-
ating into continuous sheets of cartilage. In contrast, the
corresponding leg bud cells form condensations that remain
isolated, each surrounded by cells that fail to condense or
chondrify (Downie and Newman, 1994, 1995).
Condensation of precartilage mesenchyme results from
altered adhesive interactions (reviewed in Newman and
Tomasek, 1996). Fibronectin (Frenz et al., 1989; Kosher et
al., 1982; Tomasek et al., 1982), tenascin (Mackie et al.,
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1987), NCAM (Widelitz et al., 1993), and N-cadherin (Ober-
lender and Tuan, 1994) are all elevated in foci of condensa-
tion in the developing limb and in high-density cultures of
limb bud mesenchyme. Spatiotemporal regulation of con-
densation formation depends, in part, on the activity of one
or more diffusible molecules of the TGF- family (Downie
and Newman, 1994, 1995; Leonard et al., 1991; Merino et
al., 1998; Miura and Shiota, 2000), which stimulate the
production of extracellular matrix (ECM) and cell-adhesive
proteins. Clearly, the domain of action of any initiator of
condensation formation must also be limited if condensa-
tions, and the cartilage elements that ultimately arise from
them, are to remain discrete (Newman, 1996).
In previous studies, we found that chicken wing and leg
bud precartilage mesenchymal cells exhibited responses to
various factors, such as TGF-, retinoic acid, and serum,
that affected the pattern of cartilage that formed (Downie
and Newman, 1994, 1995). In the present work, we have
studied these mesenchymal cell populations in serum-
containing culture, in which they are particularly sensitive
to inhibitory effects of ectoderm and fibroblast growth
factors (FGFs). Our objective was to gain insight into the
factors and interactions responsible for the organized pat-
terns of chondrogenesis seen in vivo and, under certain
conditions, in vitro. We have found that both limb ecto-
derm and FGF2 and -8, independently and in combination,
induce peripheral and perinodular inhibition of chondro-
genesis in wing and leg cell cultures, resulting in the
conversion of a continuous sheet of cartilage into an array
of individual nodules of cartilage surrounded by noncarti-
laginous mesenchyme.
The inhibitory effect of the FGFs did not occur in the
presence of the FGF receptor family-specific tyrosine kinase
inhibitor SU5402 (Mohammadi et al., 1997). The specific
receptor responsible for this effect was identified as FGF
receptor 2 (FGFR2). This receptor was present at sites of
incipient condensation, and both the ectoderm- and FGF-
induced perinodular inhibition of chondrogenesis failed to
occur under conditions in which the synthesis of the
receptor was blocked by transfection with an antisense
oligodeoxynucleotide (ODN) or a Morpholino oligonucleo-
tide (MO) directed against this receptor. Transfection of
chicken embryos in ovo with FGFR2 antisense oligonucle-
otides also produced abnormally short and thick cartilagi-
nous limb skeletal primordia. These results suggest that
ectodermal FGFs act on incipient precartilage condensa-
tions to limit their expansion by means of a laterally acting
inhibitor of chondrogenesis.
MATERIALS AND METHODS
Cell Culture
Fertile White Leghorn eggs were obtained from Avian Services,
Inc. (Frenchtown, NJ). Primary cultures were prepared by sepa-
rately pooling mesenchyme from the myoblast-free distal 0.3 mm
(Brand et al., 1985; Newman et al., 1981) of stage 24 (Hamburger
and Hamilton, 1951) wing and leg buds. Cells were dissociated in
1% trypsin–EDTA (Sigma), filtered through Nytex 20-m mono-
filament nylon mesh (Tetco, Briarcliff Manor, NY), and washed
with and resuspended in medium for plating at 2.5  105 (unless
otherwise specified) cells per 10-l spot.
For some experiments, ectoderm was removed from isolated
limb bud distal tips. Limb bud tips were incubated at 38°C for 10
min in calcium- and magnesium-free Earle’s balanced salt solution
(CMF EBSS; GIBCO) containing 2 mM EDTA. The tips were then
transferred to cold EBSS containing 2% fetal bovine serum (FBS;
Hyclone), and the ectoderm was released by gentle pipetting. The
mesoblasts were manually isolated and rinsed in EBSS before
dissociation and resuspension for plating as described above.
Cell spots were deposited in Costar 24-well tissue culture plates
and allowed to attach for 45 min before wells were flooded with 1
ml of medium [55% Ham’s F12, 35% Dulbecco’s modified Earle’s
Medium (DMEM)] containing 10% FBS unless otherwise indicated.
Some cultures were grown in serum-free defined medium [DM;
Paulsen and Solursh, 1988): 60% Ham’s F12, 40% DMEM, 5 g/ml
insulin (Sigma), 10 nM hydrocortisone (Sigma), 50 g/ml L-ascorbic
acid, 5 g/ml chicken transferrin (Sigma)]. Media were changed
every other day. Recombinant human FGF7, FGF2 (Isacchi et al.,
1991), mouse FGF8b (R&D Systems, Minneapolis, MN), or combi-
nations of the latter two factors, at concentrations of 10–100
ng/ml, were added to some cultures on the day of plating and with
the first change of medium on day 2. In some cultures, the
indolinone tyrosine kinase inhibitor SU5402 (Mohammadi et al.,
1997) (Calbiochem) was added at 2 M on day 2 of the culture
period. Cultures were maintained for 6 days. Hoffman Modulation
Contrast images of precartilage condensations in living cultures
were obtained with a Zeiss IM 35 inverted microscope using a 4
objective (Frenz et al., 1989).
Transfection of Precartilage Mesenchyme
Isolated stage 24–25 limb bud tips were suspended in 1 ml PBS
containing 100–300 g 15-mer antisense or control phosphorothio-
ate ODN (GeneLink, Inc., Hawthorne, NY) in a 4-mm gap BTX
electroporation cuvette. These explants were subjected to three
50-ms 2-V pulses in a BTX Electro Square Porator T820 equipped
with an Enhancer 400 oscilloscope (Genetronics, Inc., San Diego,
CA). They were then treated with trypsin and dissociated as
described above, with or without removal of ectoderm, as indicated
in the figure legends. The conditions for electroporation were
optimized by a series of transfections using a cytomegalovirus–
green fluorescent protein promoter–reporter construct (Clontech
Inc., Palo Alto, CA). The ODNs used were chicken FGFR2 anti-
sense (AN), 5-ATCCCAGCTGACCAT-3, and scrambled (SC),
5-TACGACGTCACCCTA-3. Some transfection experiments
were also performed using 25-mer Morpholino oligonucleotides
(MO; Genetools, Covallis, OR) at 10–60 M, employing the same
electroporation protocol described above. The Morpholino se-
quences used were chicken FGFR2 antisense (AMO), 5-
GCTGACCATCTTTTTAGAGTAAGTT-3, and a standard con-
trol (CMO), 5-CCTCTTACCTCAGTTACAATTTATA-3.
Transfection of Chicken Embryos in Ovo
In ovo electroporation of 5-day chick embryos with Morpholino
oligoribonucleotides was performed according to the method of
Momose et al. (1999) by using the BTX T820 electroporator
equipped with platinum and tungsten microelectrodes as the anode
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and cathode, respectively (kind gifts of Dr. Kunio Yasuda, Nara
Institute, Japan). Eggs were incubated horizontally in a humidified
atmosphere at 38.5°C for 2–3 h, at which time, 4 ml of albumin was
removed. The eggs were windowed on day 3 of incubation, sealed
with Parafilm and permitted to develop for an additional 2 days
before treatment. On day 5, 2 l of antisense or control MO (60 M
in PBS) were injected into the embryos by using a 25-l Hamilton
syringe with the electrodes placed on either side of the embryo,
flanking the dorsoventral axis. Three 50-ms pulses of 7 V were then
administered. The eggs were resealed and permitted to develop for
2–3 additional days before fixing and staining.
Alcian Blue Staining of Cultures and Embryos
Cultures were fixed in 10% formalin, 0.5% cetylpyridinium
chloride, for 5 min, washed with 3% acetic acid, pH 1.0, for 1 min,
and then stained overnight with Alcian blue 8GS (Electron Micros-
copy Sciences; 0.5% in 3% acetic acid) at pH 1.0 (Lev and Spicer,
1964). Cartilage patterns were visualized under a binocular dissect-
ing microscope after washing stained culture spots with 3% acetic
acid, pH 1.0, to remove unbound stain. Content of highly sulfated
proteoglycan was quantitatively determined by extraction of the
bound dye with 8 M guanidinium chloride followed by spectropho-
tometry using an EIA reader equipped with a 600-nm filter (Hassell
and Horigan, 1982; Leonard et al., 1989). Whole embryos were fixed
in 5% trichloroacetic acid overnight, stained overnight with
0.087% Alcian blue in acid alcohol, destained in acid alcohol
overnight, dehydrated in an ascending series of ethyl alcohol, and
cleared in methyl salicylate (Saunders, 1996).
DNA Determination
The DNA content of 6-day cell cultures was measured fluoro-
metrically in the presence of the dye Hoechst 33258 (Labarca and
Paigen, 1980). Cultures were harvested in 50-l/well 0.05 M
NaH2PO4, 2.0 M NaCl, 2 mM EDTA, pH 7.4, and disrupted by
sonication. Measurements were made in the same buffer contain-
ing 1 g/ml dye in a Hoefer TKO 100 Mini Fluorometer. Each
sample consisted of homogenate pooled from three culture wells.
Cell Proliferation Assay
Ectoderm-free leg cell cultures were plated at 1.6  105 cells per
spot in the presence of 75 ng/ml FGF2. At specified times after
plating, cells were exposed to BrdU Photolyte for 40 min, followed
by a 20-min treatment with 2% DMSO and Photolyte Enhancer
(Absolute-S SBIP Cell Proliferation Assay Kit; Molecular Probes,
Eugene, OR). Wells were washed and flooded with 70% ethanol,
and the plates stored at20°C for a minimum of 72 h. DNA breaks
were introduced by photolysis with UV light (254 nm; UV Strata-
linker 1800) for 10 min. Broken strands were labeled overnight with
rocking, by bromodeoxyuridine triphosphate (BrdUTP) using ter-
minal deoxytransferase (TdT) (TUNEL reaction) according to the
kit manufacturer’s instructions. Labeled DNA was detected by
using Alexa Fluor 488 dye-labeled anti- bromodeoxyuridine (BrdU)
antibody (room temperature, 30 min). In some cases, antibody
treatment was followed by incubation with propidium iodide/
RNase A. Cultures were viewed on an inverted microscope by
using a fluoroscein-GFP filter set (Omega Optics) for BrdU labeling
and a rhodamine filter set (Carl Zeiss, Inc.) for propidium iodide
labeling. Images were captured with an Optronics three-chip color
imaging system. Proliferation-independent DNA end labeling (e.g.,
apoptosis) was determined in cultures not treated with BrdU
Photolyte but exposed to UV light and subjected to TUNEL. No
such labeling was detected in these cells.
Quantitative Analysis of Gene Expression
Expression of the gene for the cartilage-specific proteoglycan
core protein aggrecan was quantitatively analyzed by using reverse
transcription followed by real-time polymerase chain reaction with
the LightCycler System (Roche Laboratories). The SYBR Green-I
dye binding method was used, followed by melting peak analysis of
specific product accumulated after 40 cycles, which was within the
exponential phase of amplification of the aggrecan product. Actin
expression was used as an internal standard. Total RNA was
extracted from untreated (82 wells) and FGF2 and -8-treated (65
wells) micromass cultures prepared from 5-day leg bud precartilage
mesenchyme and grown for 3 days. Treated cultures contained 80
ng/ml FGF2 and 40 ng/ml FGF8 throughout the culture period.
Primers used for reverse transcription and amplification were
chicken aggregan (Chandrasekaran and Tanzer, 1993; Accession
No. M88101), forward primer: 5-TCTGATCACAGGCGTT-
TCAG-3; reverse primer: 5-AGTAGCAGTGGCTGGCAGAT-3;
chicken -actin (Wang and Morais; Accession No. L08165), forward
primer: 5-AGGCTGTGCTGTCCCTGTAT-3; reverse primer: 5-
GCTGTGGTGGTGAAGCTGTA-3.
Immunochemical Detection of FGFR2
Leg cell cultures incubated for various times in the presence of
80 ng/ml FGF2 and 40 ng/ml FGF8 were fixed in 2% formaldehyde/
PBS for 20 min, washed in PBS, and incubated in 1% Tergitol
NP-40 (Sigma) in PBS for 10 min (Downie and Newman, 1995).
They were then blocked for 2–3 h (2% nonfat dry milk, 5% normal
rabbit serum in PBS), followed by an overnight incubation at 4°C
with a 1:50 dilution in blocking solution of a goat anti-FGFR2/bek
polyclonal antibody with broad species reactivity but nonreactivity
with either FGFR1 or FGFR3 (FGFR2abG; Research Diagnostics
Inc.). Cultures were then incubated in CY3-conjuagated rabbit
anti-goat secondary antibody (Jackson Laboratories; 1:200) for 2 h at
room temperature in blocking solution (2% dry milk, in PBS),
washed three times in PBS, and visualized by using a rhodamine
filter set. For immunoblot analysis, cell cultures transfected with
antisense or control ODN or MO were solubilized in 2 sample
buffer [50 mM Tris, pH 6.8, 1% sodium dodecyl sulfate (SDS), 20%
glycerol, 15 mM dithiothreitol, and 7.5 g/ml each of leupeptin and
chymostatin], at a ratio of three cultures per 50 l buffer. The tissue
was disrupted by sonication and heated at 100°C for 2 min.
Samples were loaded into 12% SDS–polyacrylamide gels (Novex/
Invitrogen, Carlsbad, CA) and electrophoresed for 1.5 h. Proteins
were transferred to PVDF membrane (Millipore) by electroblotting
for 1 h in 10 mM Tris–glycine, pH 11.0, 10% MetOH. Blots were
blocked for 1 h at 37°C in blocking buffer (33 mM Tris base, 137
mM NaCl, 5 mM KCl, 5% dry milk) then incubated overnight with
rocking at 4°C using goat anti-FGFR2 polyclonal antibody diluted
1:1000 in blocking buffer. Blots were washed with TTBS (Tris-
buffered saline: 33 mM Tris base, 500 mM NaCl, 0.01% Tween),
incubated for 1 h with horseradish peroxidase (HRP)-conjugated
rabbit anti-goat IgG (Jackson ImmunoResearch, West Grove, PA;
1:25,000) in TTBS containing 1% gelatin, and washed 5–10 times
with TTBS. Stained bands were visualized by using the ECL Plus
detection kit (Amersham–Pharmacia) according to the manufactur-
er’s instructions.
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RESULTS
Ectoderm Induces Perinodular Inhibition of
Chondrogenesis of Limb Bud Mesenchyme in Vitro
In previous studies, stage 24–26 wing and leg bud pre-
cartilage mesenchymal cells were shown to exhibit dif-
ferent patterns of chondrogenesis in serum-free culture as
well as distinct responses to the addition of serum to the
culture medium (Downie and Newman, 1994, 1995). We
subsequently found that the response of these mesenchy-
mal populations to serum was influenced by whether or
not limb ectoderm was present in the cultures. We there-
fore decided to study the effects of ectoderm in serum-
FIG. 1. Effect of ectoderm on cartilage pattern in vitro. (Upper left) Cultures established from wing bud mesenchyme from which ectoderm was
removed, grown in serum-supplemented medium, form a sheet-like mass of cartilage. (Lower left) In the presence of ectoderm, a central mass of
cartilage forms which is surrounded by a large zone of nonchondrogenic cells. (Upper right) Leg cell cultures devoid of ectoderm, grown in
serum-supplemented medium, also form a sheet-like mass of cartilage, whereas (Lower right) the presence of ectoderm leads to the formation of
one or more central nodules surrounded by zones of nonchondrogenic tissue, similar to the effect seen in wing cell cultures. Alcian blue-stained
cultures photographed through a dissecting microscope. Culture diameters are approximately 5 mm.
FIG. 2. (A) Effect of increasing concentrations of FGFs on the formation of precartilage condensations by limb bud precartilage cells in
vitro. Leg cell cultures were grown for 3 days in the presence of the indicated amounts (ng/ml) of FGF2 and FGF7. Living cultures were
visualized by Hoffman Modulation contrast microscopy (4 objective) (Frenz et al., 1989). FGF2-treated, but not FGF7-treated, cultures
exhibit a nodular appearance. (B) Effect of FGF2 on cartilage pattern in serum-containing cultures of limb bud mesenchyme. Leg cell
cultures were grown in the absence of ectoderm. A continuous sheet of cartilage formed in the absence of FGF2 (control, C). Increasingly
larger regions of noncartilaginous tissue appear within the cartilage mass with increasing concentrations of FGF2 (25, 50, and 100 ng/ml).
Staining and photography as in Fig. 1.
FIG. 3. Induction of perinodular inhibition in limb cell cultures is independent of cell density. Cultures plated at 2.5  105 (standard
density, SD) or 5.0  105 (high density, HD) cells per 10-l spot were grown in the absence or presence of 25 ng/ml FGF2. Staining and
photography as in Fig. 1.
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containing cultures. Alcian blue staining at pH 1.0, a
quantitative index of cartilage development in these cul-
tures (Leonard et al., 1989), was used to monitor the
pattern of chondrogenesis. We found that serum-
containing wing cell cultures grown in the absence of
ectoderm formed a continuous, sheet-like mass of carti-
lage by 6 days of culture (Fig. 1, upper left). If limb
ectoderm was included in the cultures, however, the
extent of the cartilaginous mass was severely reduced
(Fig. 1, lower left). In this case, a single large nodule was
surrounded by a peripheral halo of nonchondrified con-
nective tissue (see below).
For serum-containing leg cell cultures, the response to
ectoderm was equally dramatic: in the absence of ectoderm,
these cultures formed a sheet of cartilage like that produced
by wing cells grown under the same conditions (Fig. 1,
upper right). But when leg cultures were grown in the
presence of ectoderm, they formed one or more nodules of
cartilage surrounded by cells that failed to undergo chon-
drogenesis (Fig. 1, lower right). The effects of ectoderm in
inducing perinodular inhibition were seen both in cultures
in which limb bud distal tips were dissociated without prior
removal of ectoderm, and in cultures in which the ectoderm
had been removed before dissociation and added back once
the mesenchymal micromasses were established (not
shown).
FGF2 and -8 Inhibit Chondrogenesis of Limb
Mesenchyme in Vitro and Cooperatively Substitute
for Ectoderm in Mediating Perinodular Inhibition
To determine whether the effects of ectoderm on the
pattern of cartilage differentiation in serum-containing leg
mesenchymal cell cultures were due to known limb ecto-
dermal products, we cultured ectoderm-free leg cells in the
presence of serum and various concentrations of FGF2 and
FGF8.
At 3 days of culture, when control leg cells were first
massing into a large condensation, progressively higher
concentrations of FGF2 caused the single condensation to
break up into separate condensing masses. In contrast, the
same concentrations of the mesodermally produced factor
FGF7 had no such effect (Fig. 2A). FGF2-treated cultures
showed a pattern of Alcian blue-positive cartilage forma-
tion by 6 days that was comparable to that in cultures
grown in the presence of ectoderm. In particular, the
sheet-like mass of cartilage seen in ectoderm-free controls
was constricted and/or interrupted. Moreover, the amount
of cartilage formed was reduced, in a fashion that reflected
FIG. 4. Cell proliferation in 1-day leg cell cultures. Cells grown in
the presence of 75 ng/ml FGF2 were pulse labeled for 40 min with
BrdU after 23 h in culture. (a) BrdU label (green); (b) phase contrast
image of same field; (c) propidium iodide label (red) of same field; (d)
Lack of detection of BrdU label in cells not exposed to BrdU in
culture, but exposed to UV light and assayed for DNA breaks by
TUNEL-dependent BrdU incorporation (see Materials and Meth-
ods); (e) phase contrast image of field in (d). The control represented
by (d) and (e) indicates that these cells are not apoptotic and that
labeling in (a) is DNA synthesis-dependent. Numbers on (b) indi-
cate (1, 3) regions of incipient condensation with, respectively, low
and high BrdU labeling, and (2, 4) noncondensing regions with,
respectively, low and high BrdU labeling. (a–c) Photographed using
a 16 and (d, e) using a 32 objective. Examination of 15
FGF2-treated cultures at 23–24 h and 13 h (not shown) disclosed no
relationship between condensation and proliferation rate.
TABLE 1
Effect of FGF2 on Accumulation of Cartilage Proteoglycan in
Cultures of Wing Bud Precartilage Mesenchyme
Treatment Proteoglycan
Control 100a
1b 88.0  2.9
5 81.9  2.6
15 72.9  4.9
25 67.9  4.2
50 51.1  4.7
100 44.7  2.1
Note. Cultures were grown for 6 days in serum-containing
medium in the presence of the designated concentrations of FGF2,
added on the day after cultures were established.
a Data represent percentage of control values of OD600 of GuHCl-
extracted Alcian blue stain from three to five stage 24 wing tip cell
cultures.
b ng/ml FGF2.
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the presence of nonchondrogenic tissue surrounding the
cartilaginous nodules (Fig. 2B; leg cultures shown; similar
results were also obtained with wing cultures).
After 6 days of culture, wing bud cells that had been
exposed to 25 ng/ml of FGF2 contained one major and a few
scattered peripheral nodules of cartilage instead of the
uniform sheet of cartilage formed by control cultures (Fig. 3,
lower left). In some cultures, we increased the initial
plating density of cells from 2.5 to 5.0  105 per 10-l spot
to determine whether enhanced cell contact could over-
come the inhibitory effect. However, the addition of FGF2
still led to a final chondrogenic pattern in which nodules of
cartilage were separated by domains in which chondrogen-
esis had failed to progress (Fig. 3, lower right).
The effect of FGF2 on cartilage differentiation, while
dose-dependent, exhibited a plateau. The extent to which
chondrogenesis was inhibited by FGF2 was quantitated
spectrophotometrically. Corresponding to the formation of
regions of perinodular inhibition, there was a dose-
dependent decline in cartilage formation. At 50 ng/ml
FGF2, only half the control amount of stainable matrix was
produced by wing cell cultures. This level of inhibition was
only slightly increased by further raising the FGF2 concen-
tration to 100 ng/ml (Table 1).
The observed perinodular inhibition was an effect on
cartilage differentiation, not cell proliferation. For both
wing and leg cells, mesenchymal condensations in 3-day
ectoderm-containing or FGF2-treated (Fig. 2A) cultures
were surrounded by a layer of less condensed mesenchyme,
and Alcian blue-stained nodules at 6 days (Figs. 1 and 2B)
were surrounded by dense, but unstained, tissue. The DNA
content of wing and leg cultures grown in the presence of
ectoderm was no different from cultures grown in its
absence. The presence of 50 ng/ml FGF2 led to a slightly
increased DNA content relative to ectoderm-lacking con-
trols (Table 2). On the cellular level, there was no strict
relationship between proliferation rate and condensation
formation: FGF2-treated (75 ng/ml) cultures exposed to the
thymidine analogue BrdU for 40 min at 23 h of culture,
when incipient condensations were first apparent, con-
tained areas of high and low DNA synthesis-dependent
labeling in both condensing and noncondensing regions
(Fig. 4). The suppression of chondrogenesis in the zones
peripheral to the condensations in FGF2-treated cultures
was therefore not due to differential proliferation of con-
densing and noncondensing mesenchyme.
Addition of the ectodermally produced factor FGF8 to
wing and leg cultures also had an inhibitory effect on
cartilage formation (Fig. 5). Limb bud ectoderm is a source
of several FGFs, and FGF2 and FGF8 are the predominant
ones supplied by the apical ectodermal ridge (AER) during
the formation of digits from the distal tip of the 5-day
chicken limb bud (Martin, 1998). We therefore studied the
effect of combinations of the two factors on the cartilage
pattern generated by the mesenchymal cells. Compared
with 50 or 100 ng/ml of either factor, 50 ng each of both
factors together produced an array of nodules that were
relatively uniform in size, well spaced, and similar in scale
to cartilaginous skeletal primordia in the developing limb
in vivo (Fig. 5). As with FGF2 alone, combinations of FGF2
and FGF8 led to modest increases in cell proliferation,
despite decreases in Alcian blue staining (Table 2).
FGF2 and -8 Inhibit Chondrogenesis at the Level of
Gene Expression
Ectoderm and FGFs could potentially inhibit the forma-
tion of cartilage at several different levels. The most rel-
evant level of regulation from the standpoint of skeletal
pattern formation would be that of cartilage-specific gene
expression. We used quantitative real-time PCR to deter-
mine the effects of exposure to a combination of FGF2 and
-8 on expression of the gene for the cartilage-specific pro-
teoglycan core protein, aggregan (Upholt and Olsen, 1991;
Chandrasekaran and Tanzer, 1993). We found that exposure
of leg cell cultures to FGF2 and -8 caused a nearly 50%
reduction in the amount of aggrecan RNA in these cultures
(Table 3). This indicates that the inhibition of Alcian blue
staining by FGF (Figs. 2B and 3; Table 1) reflected inhibition
of cartilage-specific gene expression.
Ectoderm and FGFs Induce Perinodular Inhibition
via FGF Receptor 2
Signaling by FGFs is mediated by at least four FGF
receptors (Givol and Yayon, 1992), three of which, FGFR1,
FGFR2, and FGFR3, are expressed during limb development
(Xu et al., 1999). The indolinone tyrosine kinase inhibitor
SU5402 is specific for the FGFR family of receptors, con-
tacting a peptide motif in the hinge region between the two
kinase lobes (Mohammadi et al., 1997), which is conserved
in chicken FGFR1, -2, and -3 (Pasquale, 1990). Limb cell
cultures grown in the presence of a combination of FGF2
and -8 formed a solid sheet of cartilage over the majority of
the culture area when treated with SU5402 (Fig. 6), indicat-
ing involvement of standard FGF receptors in the induction
of perinodular inhibition of chondrogenesis by the FGFs.
In the developing limb, FGFR1 mRNA is widely dis-
persed throughout the precartilage mesenchyme prior to
the formation of condensations (Delezoide et al., 1998;
Peters et al., 1992; Szebenyi et al., 1995). FGFR3 mRNA, in
contrast, does not appear until cartilage has differentiated
(Delezoide et al., 1998; Szebenyi et al., 1995). FGFR2
mRNA first appears at significant levels in precartilage
condensations (Peters et al., 1992; Szebenyi et al., 1995;
Delezoide et al., 1998). We assayed for the presence of
FGFR2 protein in FGF2- and -8-treated leg cell cultures by
indirect immunofluorescence (Fig. 7). During the course of
development the first FGFR2, immunoreactive cells appear
around the same time the first evidence of cell clustering
can be observed (17 h; Fig. 7, upper pair of panels). These
rounded cells were not always part of multicell clusters. By
24 h, confined groups of intensely immunoreactive cells
coincided with expanding condensations, but isolated cells
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continued to appear as well (Fig. 7, second and third pairs of
panels). By 48 h, all immunoreactivity was gone in the
maturing condensations (Fig. 7, fourth pair of panels).
FGFR2 is therefore present in incipient condensations just
at the time at which limb mesenchyme responds to FGF2
and -8 by forming regions of perinodular inhibition.
Transfection of wing or leg mesenchyme with an anti-
sense ODN directed against FGFR2 completely blocked the
ability of ectoderm (Figs. 8A and 8B), or a combination of
FGF2 and -8 (Fig. 8C), to induce perinodular inhibition.
Immunoblot analysis using a FGFR2-specific polyclonal
antibody shows that the antisense treatment is effective at
reducing receptor levels (Fig. 8D).
Because antisense ODN treatment acts by inducing
RNase H and can thereby have nonspecific effects, we also
designed an antisense MO spanning the translational start
site of chicken FGFR2. Antisense MOs act by specifically
blocking translational initiation and are thus less prone
than ODN to spurious effects (Heasman et al., 2000; Sum-
merton, 1999). Similarly to the antisense phosphorothioate
ODN, the antisense MO suppressed the formation of FGF2-
and -8-stimulated zones of perinodular inhibition in leg
(Fig. 9A) and wing cultures (not shown). When the antisense
MO was introduced by electroporation into living embryos
at 5 days of development when midlimb and digital pattern-
ing is occurring, it induced abnormally short and thick
zeugopodal and autopodal elements in the developing leg
(Fig. 9B). Transfection with control MO did not lead to
skeletal defects.
DISCUSSION
We have shown that FGFs produced by the ectoderm of
the developing avian limb bud affect chondrogenic pattern
formation by inducing the formation of zones of perinodu-
lar inhibition around developing precartilage condensa-
tions. Previous studies reported that partial removal of the
dorsal limb bud ectoderm in developing chicken limbs in
ovo leads, in many instances, to thickening and fusions ofFIG. 5. Synergistic effect of FGF2 and FGF8 on the induction of
the perinodular inhibition of chondrogenesis in ectoderm-free wing
cell (left panels) and leg cell (right panels) cultures. (Top row)
control cultures without FGFs; (Second through fourth rows)
cultures grown in the presence of 100 ng/ml FGF2, 100 ng/ml
FGF8, and 50 ng/ml of each of the factors, respectively. Staining
and photography as in Fig. 1.
FIG. 6. Suppression of perinodular inhibition of chondrogenesis
by a FGF receptor tyrosine kinase inhibitor. Ectoderm-free leg cell
cultures produced a continuous sheet of cartilage (left). In the
presence of 80 ng/ml FGF2 and 20 ng/ml FGF8, the cartilaginous
sheet of cells was transformed into a nodular pattern with zones of
perinodular inhibition (middle). Addition of the inhibitor SU5402
(2 M) to FGF-treated cultures suppressed the formation of nodules
and led to the replacement of zones of inhibition by cartilage
(right).
TABLE 2
DNA Content of 6-Day Limb Precartilage Mesenchymal
Cultures Grown in the Absence and Presence
of Ectoderm and FGFs
Experiment
Treatment
Ecto  FGFs Ecto Ecto  FGFsa
1. Legs 2.5 2.5 3.3*
2. Wings 4.1 3.6 5.2*
3. Legs 3.9 3.6 4.1
4. Wings 2.5 2.4 3.2
Note. Values are expressed as mean g DNA per culture well.
Each data point represents measurements of three to seven samples
consisting of combined extracts from three culture wells. Standard
errors of mean were 15% of mean.
a FGFs for Experiments were as follows: Expt. 1, 50 ng FGF2/ml;
Expts. 2–4, 60 ng FGF2  40 ng FGF8 per ml.
*, Significantly different from Ecto  FGFs.
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skeletal elements (Martin and Lewis, 1986). In vitro analy-
sis showed that inclusion of the AER, or dorsal and ventral
limb bud ectoderm, suppressed chondrogenesis in limb cell
cultures (Solursh et al., 1981). Those investigators sug-
gested that the ectodermal product responsible for the
suppression of chondrogenesis was hyaluronan (Solursh and
Reiter, 1988; Solursh et al., 1981). But because all regions of
the chicken limb bud ectoderm produce FGF2 (Savage et al.,
1993), and during the digit-forming stage of development,
the AER produces FGF8 (Martin, 1998), the earlier findings
are likely to have been attributable, in part, to the effect of
ectodermal FGFs.
An inhibitory effect of limb bud ectoderm on chondro-
genesis was also suggested by studies in which removal of
portions of the AER or dorsal ectoderm from the developing
limb bud led to interdigital chondrogenesis (Hurle and
Gan˜an, 1986). Because the presence of an intact ectoderm
during development does not suppress digital (or other
normal) chondrogenesis, these earlier experiments sug-
gested that ectoderm is an indirect, rather than direct,
inhibitor of chondrogenesis.
In the present studies, FGF2 was unable to suppress more
than about 55% of the production of Alcian blue-staining
matrix in wing cultures (Table 1). Moreover, neither ecto-
derm (Fig. 1) nor the combination of FGF2 and -8 (Fig. 5)
suppressed chondrogenesis in a spatially uniform fashion,
but rather allowed the formation of a cartilaginous mass
surrounded by a set of relatively regularly spaced nodules.
Together, these results provide additional evidence that
ectoderm and its FGFs are indirect inhibitors of chondro-
FIG. 7. Spatiotemporal expression of FGFR2 protein in FGF2-, -8-treated leg cell cultures. Each pair of panels shows an immunostained
(left) and phase contrast (right) image of the same microscopic field. Top row, a culture at 17 h; second and third rows, cultures at 24 h;
fourth row, a culture at 48 h. Objective magnification, 25 in all cases.
FIG. 8. Ectoderm- and FGF-induced perinodular inhibition of chondrogenesis is mediated by FGFR2. Electroporation of (A) wing or (B) leg cell
cultures with an antisense ODN directed against FGFR2 (As) caused the disappearance of the zone of perinodular inhibition of chondrogenesis
induced by the presence of ectoderm (Top left), transforming it into cartilage (Bottom right). The cultures thereby assume the same morphology
as those grown in the absence of ectoderm (Top right). Transfection with a scrambled ODN (Scr) caused virtually no change in the pattern of
ectoderm-containing cultures (Bottom left). One or a few central cartilaginous nodules surrounded by zones of noncartilaginous tissue still
formed. (C) Leg cultures grown in serum-supplemented medium without ectoderm (Top right), when treated with 50 ng/ml each of FGF2 and
FGF8 formed a nodular pattern of cartilage (Top left). Cartilage formation was enhanced and nodularity was suppressed in cultures electroporated
with antisense ODN directed against FGFR2 (Bottom right). Electroporation with a scrambled ODN had no effect on the generation of zones of
internodular inhibition (Bottom left). (D) Immunoblot analysis of FGFR2 expression shows that a band of 90 kDa detected by an anti-FGFR2
antibody is greatly reduced in cultures electroporated with antisense (A) but not scrambled (S) ODN, or antisense (M) but not control (C) MO.
Cultures for the ODN experiments were grown in the presence of 50 ng/ml each of FGF2 and FGF8. Cultures for the MO experiments were grown
in the presence of 80 ng/ml FGF2 and 20 ng/ml FGF8. Staining and photography as in Fig. 1.
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genesis. In addition, the mediation of both ectodermal and
FGF inhibition of chondrogenesis by FGFR2, which is
localized to incipient centers of chondrogenesis in vivo
(Peters et al., 1992; Szebenyi et al., 1995; Delezoide et al.,
1998) and in vitro (Szebenyi et al., 1995), and Fig. 7, argues
strongly for an indirect mechanism. Taken together, these
results suggest that the inhibitory activity elicited by ecto-
derm, or the combination of FGF2 and -8, spares certain
centers of condensation (perhaps those that are initiated
earliest), but prevents their expansion by affecting cells that
would otherwise be recruited into condensations later dur-
ing development. In keeping with this are studies that
indicate that developing chicken and mouse digits are
themselves sources of anti-chondrogenic activity (Gan˜an et
al., 1994; Lee et al., 1994).
Given the commonality of their receptors, the finding
that FGF2 and FGF8 have distinct effects on an apparently
uniform cell type is unexpected, but not unprecedented
(Hajihosseini and Dickson, 1999). Indeed, the factors have
different patterning effects when applied separately to de-
veloping limbs in vivo (Akiba et al., 2001), and it is
therefore reasonable to expect that their effects together
would be different from each separately. Our in vitro
evidence that they are required in combination in order to
produce a pattern of regular cartilage nodules in distal tip
mesenchyme suggests a reason for observed transitions in
the complex of FGFs produced by the limb bud ectoderm at
successive stages of development (Martin, 1998).
Previous work has provided evidence that initiation and
expansion of precartilage condensations in the developing
limb are regulated by one or more members of the TGF-
family (Downie and Newman, 1994, 1995; Leonard et al.,
1991; Miura and Shiota, 2000). Because TGF- is positively
autoregulatory (Van Obberghen-Schilling et al., 1988), if
unchecked it would lead to the formation of condensations
and resulting cartilage elements of indefinite size. Prepat-
terns of TGF- immunoreactivity precede overt condensa-
tion of limb bud mesenchyme by at least half a day (Leonard
et al., 1991); it is at this early stage that the effects of FGFs
in restricting the expansion of precartilage condensations
must be exerted. The release of a diffusible or otherwise
laterally transmissible inhibitor of condensation from the
centers of incipient condensation (Fig. 10) could perform
this function. Our data demonstrate that blocking an en-
dogenous FGF signaling pathway enhances the amount of
cartilage formed (Figs. 6 and 8). Furthermore, FGF2 does not
act by differentially enhancing or suppressing proliferation
of condensing or noncondensing mesenchyme (Fig. 4).
Therefore, the production of a lateral inhibitor at the sites
of incipient condensation is the most likely mechanism for
generation of the nodular pattern. Although our evidence
for an inhibitor is indirect, it is notable that, in zebrafish
embryos, FGF3 induces the expression of chordino, a se-
FIG. 9. Suppression of perinodular inhibition of chondrogenesis
by antisense MO. (A) Ectoderm-free leg cell cultures grown in the
presence of exogenous FGF2 and FGF8 exhibited nodularity when
electroporated with control MO. In cultures transfected with
FGFR2 antisense MO, zones of perinodular inhibition did not
appear. Similar results obtained in leg cultures with different
combinations of the FGFs (70 ng/ml FGF2 30 ng/ml FGF8 and 80
ng/ml FGF2  20 ng/ml FGF8) and in wing cultures (not shown)
confirmed the robustness of the effect. (C) Cartilage patterns in legs
of stained and cleared 7-day chicken embryos. The embryo on the
right was electroporated with FGFR2 antisense MO. Note that the
elements of zeugopod and autopod are abnormally shortened and
broadened and that the tarsal elements are fused in the antisense-
transfected embryo (detail, right panel).
TABLE 3
Quantitation of Aggrecan Gene Expression in 3-Day Limb
Precartilage Mesenchymal Cultures Grown in the Presence of
FGF2 and 8
Sample Primers Peak area Tm Aggrecan/Actin
Untreated Aggrecan 7.44 87.8
Untreated Actin 5.30 89.1 1.4
FGF2-, 8-treated Aggrecan 4.46 87.8
FGF2-, 8-treated Actin 5.93 89.2 0.75
Note. Each sample was derived from the pooled total RNA from
multiple 3-day leg bud micromass cultures grown in the absence
and presence of 80 ng FGF2  40 ng FGF8. Equal amounts of RNA
were used for each reverse transcription reaction and corresponding
gene-specific sequences were quantitated by using the LightCycler
with the SYBR Green-I-dye binding method (see Materials and
Methods).
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FIG. 10. Schematic model for formation of discrete cartilaginous skeletal elements by a self-organizing biochemical network. (Top)
Positively autoregulatory activator of chondrogenesis (red arrows), such as TGF-, stimulates production of ECM and cell adhesion
molecules, and itself, leading to expanding condensation and unpatterned mass of cartilage. (Bottom) Production from the sites of activation
of diffusible inhibitor (pink arrows) of the activator, or of its downstream effectors, limits expansion of condensations and produces pattern
of well-spaced cartilage elements.
FIG. 11. Spatiotemporal expression of FGF receptors in the developing chicken limb. FGFR1 is expressed in precartilage mesenchyme,
FGFR2 in condensing mesenchyme, and FGFR3 in cartilage. Based on Szebenyi et al. (1995). A similar developmental pattern of FGFR
expression occurs in the mouse (Peters et al., 1992, 1993) and the human (Delezoide et al., 1998).
279Perinodular Inhibition of Limb Chondrogenesis
© 2002 Elsevier Science (USA). All rights reserved.
creted antagonist of members of the TGF- superfamily
(Koshida et al., 2002).
FGF2 is known to promote outgrowth and distal progres-
sion of cartilage development in limb bud mesenchyme,
and indeed can substitute for the corresponding functions of
the AER (Fallon et al., 1994). It is important to recognize,
however, that signaling by FGFs is transduced by three
different receptors in the developing limb that appear in
distinct spatiotemporal patterns (Fig. 11); activation of each
of these receptors may have distinct effects on cellular
function. FGFR1 is widely dispersed throughout the precar-
tilage mesenchyme prior to the formation of condensations
(Fallon et al., 1994; Patstone et al., 1993; Peters et al., 1992;
Szebenyi et al., 1995) and is therefore a likely mediator of
the mitogenic effect of the growth factor during the out-
growth phase. FGFR3, in contrast, does not appear until
cartilage has differentiated (Peters et al., 1993; Szebenyi et
al., 1995), and its activation appears to transduce a negative
effect on cartilage growth, particularly in the epiphyseal
plates (Deng et al., 1996; Shiang et al., 1994; Webster and
Donoghue, 1996). Most significantly for the present study,
FGFR2 first appears in the mesoblast of the developing limb
in the condensing precartilage mesenchyme (Delezoide et
al., 1998; Peters et al., 1992; Szebenyi et al., 1995), and is
thus ideally situated to mediate the production of a laterally
acting anti-chondrogenic factor.
Apert syndrome in the human, the characteristic pheno-
type of which includes synostoses and severe syndactyly, is
associated with a set of mutations in FGFR2 (Oldridge et
al., 1999; Wilkie et al., 1995). Because certain Apert syn-
drome FGFR2s have abnormally high affinity for a subset of
normal ligands (Anderson et al., 1998) or exhibit reduced
specificity of ligand-binding (Oldridge et al., 1999; Yu et al.,
2000), it has been suggested that the range of phenotypic
effects results from FGFR2 gain-of-function (Hajihosseini et
al., 2001; Yu and Ornitz, 2001). The specific function gained
under these circumstances, however, is not known, and the
relationship between these biochemically defined activities
and developmental function is unclear. Our in vitro and in
vivo results suggest that one normal function of mesenchy-
mal FGFR2 is to mediate perinodular inhibition of chon-
drogenesis. Further studies may determine whether hyper-
activation of FGFR2 may, by exceeding a threshold,
abrogate this function, thereby bringing about the syndac-
tyly seen in Apert patients.
ACKNOWLEDGMENTS
This work was supported by grants from the National Institutes
of Health (HD37194 to S.A.N. and GM54604 to P.A.M.), the
National Science Foundation (IBN-9603838 and IBN-0083653 to
S.A.N.), and the government of the Arab Republic of Egypt through
the U.S.-Egypt Channel Program (to M.M.).
REFERENCES
Akiba, E., Yonei-Tamura, S., Yajima, H., Omi, M., Tanaka, M.,
Sato-Maeda, M., Tamura, K., and Ide, H. (2001). Fibroblast
growth factor-induced gene expression and cartilage pattern
formation in chick limb bud recombinants. Dev. Growth Differ.
43, 165–175.
Anderson, J., Burns, H. D., Enriquez-Harris, P., Wilkie, A. O. M.,
and Heath, J. K. (1998). Apert syndrome mutations in fibroblast
growth factor receptor 2 exhibit increased affinity for FGF ligand.
Hum. Mol. Genet. 7, 1475–1483.
Brand, B., Christ, B., and Jacob, H. J. (1985). An experimental
analysis of the developmental capacities of distal parts of avian
leg buds. Am. J. Anat. 173, 321–340.
Chandrasekaran, L., and Tanzer, M. L. (1993). Molecular cloning of
chicken aggrecan. Biochem. J. 296, 885–887.
Delezoide, A. L., Benoist-Lasselin, C., Legeai-Mallet, L., Le Merrer,
M., Munnich, A., Vekemans, M., and Bonaventure, J. (1998).
Spatio-temporal expression of FGFR 1, 2 and 3 genes during
human embryo–fetal ossification. Mech. Dev. 77, 19–30.
Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A., and Leder, P.
(1996). Fibroblast growth factor receptor 3 is a negative regulator
of bone growth. Cell 84, 911–921.
Downie, S. A., and Newman, S. A. (1994). Morphogenetic differ-
ences between fore and hind limb precartilage mesenchyme:
Relation to mechanisms of skeletal pattern formation. Dev. Biol.
162, 195–208.
Downie, S. A., and Newman, S. A. (1995). Different roles for
fibronectin in the generation of fore and hind limb precartilage
condensations. Dev. Biol. 172, 519–530.
Fallon, J. F., Lopez, A., Ros, M. A., Savage, M. P., Olwin, B. B., and
Simandl, B. K. (1994). FGF-2: Apical ectodermal ridge growth
signal for chick limb development. Science 264, 104–107.
Frenz, D. A., Jaikaria, N. S., and Newman, S. A. (1989). The
mechanism of precartilage mesenchymal condensation: A major
role for interaction of the cell surface with the amino-terminal
heparin-binding domain of fibronectin. Dev. Biol. 136, 97–103.
Gan˜an, Y., Macias, D., and Hurle, J. M. (1994). Pattern regulation in
the chick autopodium at advanced stages of embryonic develop-
ment. Dev. Dyn. 199, 64–72.
Givol, D., and Yayon, A. (1992). Complexity of FGF receptors:
Genetic basis for structural diversity and functional specificity.
FASEB J. 6, 3362–3369.
Hajihosseini, M. K., and Dickson, C. (1999). A subset of fibroblast
growth factors (Fgfs) promote survival, but Fgf-8b specifically
promotes astroglial differentiation of rat cortical precursor cells.
Mol. Cell. Neurosci. 14, 468–485.
Hajihosseini, M. K., Wilson, S., De Moerlooze, L., and Dickson, C.
(2001). A splicing switch and gain-of-function mutation in FgfR2-
IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like pheno-
types. Proc. Natl. Acad. Sci. USA 98, 3855–3860.
Hall, B. K., and Miyake, T. (1995). Divide, accumulate, differenti-
ate: Cell condensation in skeletal development revisited. Int. J.
Dev. Biol. 39, 881–893.
Hall, B. K., and Miyake, T. (2000). All for one and one for all:
Condensations and the initiation of skeletal development. Bioes-
says 22, 138–147.
Hamburger, V., and Hamilton, H. L. (1951). A series of normal
stages in the development of the chick embryo. J. Morphol. 88,
49–92.
280 Moftah et al.
© 2002 Elsevier Science (USA). All rights reserved.
Hassell, J. R., and Horigan, E. A. (1982). Chondrogenesis: A model
developmental system for measuring teratogenic potential of
compounds. Teratog. Carcinog. Mutagen. 2, 325–331.
Heasman, J., Kofron, M., and Wylie, C. (2000). Beta-catenin signal-
ing activity dissected in the early Xenopus embryo: A novel
antisense approach. Dev. Biol. 222, 124–134.
Hurle, J. M., and Gan˜an, Y. (1986). Interdigital tissue chondrogen-
esis induced by surgical removal of the ectoderm in the embry-
onic chick leg bud. J. Embryol. Exp. Morphol. 94, 231–244.
Isacchi, A., Statuto, M., Chiesa, R., Bergonzoni, L., Rusnati, M.,
Sarmientos, P., Ragnotti, G., and Presta, M. (1991). A six-amino
acid deletion in basic fibroblast growth factor dissociates its
mitogenic activity from its plasminogen activator-inducing ca-
pacity. Proc. Natl. Acad. Sci. USA 88, 2628–2632.
Kosher, R. A., Walker, K. H., and Ledger, P. W. (1982). Temporal
and spatial distribution of fibronectin during development of the
embryonic chick limb bud. Cell Differ. 11, 217–228.
Koshida, S., Shinya, M., Nikaido, M., Ueno, N., Schulte-Merker, S.,
Kuroiwa, A., and Takeda, H. (2002). Inhibition of BMP activity by
the FGF signal promotes posterior neural development in ze-
brafish. Dev. Biol. 244, 9–20.
Labarca, C., and Paigen, K. (1980). A simple, rapid, and sensitive
DNA assay procedure. Anal. Biochem. 102, 344–352.
Lee, K. K. H., Li, F. C. H., Yung, W. T., Kung, J. L. S., Ng, J. L., and
Cheah, K. S. E. (1994). Influence of digits, ectoderm, and retinoic
acid on chondrogenesis by mouse interdigital mesoderm in
culture. Dev. Dyn. 201, 297–309.
Leonard, C. M., Bergman, M., Frenz, D. A., Macreery, L. A., and
Newman, S. A. (1989). Abnormal ambient glucose levels inhibit
proteoglycan core protein gene expression and reduce proteogly-
can accumulation during chondrogenesis: possible mechanism
for teratogenic effects of maternal diabetes. Proc. Natl. Acad. Sci.
USA 86, 10113–10117.
Leonard, C. M., Fuld, H. M., Frenz, D. A., Downie, S. A., Massague´,
J., and Newman, S. A. (1991). Role of transforming growth
factor-beta in chondrogenic pattern formation in the embryonic
limb: stimulation of mesenchymal condensation and fibronectin
gene expression by exogenous TGF-beta and evidence for endog-
enous TGF-beta-like activity. Dev. Biol. 145, 99–109.
Lev, R., and Spicer, S. S. (1964). Specific staining of sulfate groups
with alcian blue at low pH. J. Histochem. Cytochem. 12, 309.
Mackie, E. J., Thesleff, I., and Chiquet-Ehrismann, R. (1987).
Tenascin is associated with chondrogenic and osteogenic differ-
entiation in vivo and promotes chondrogenesis in vitro. J. Cell
Biol. 105, 2569–2579.
Martin, G. R. (1998). The roles of FGFs in the early development of
vertebrate limbs. Genes Dev. 12, 1571–1586.
Martin, P., and Lewis, J. (1986). Normal development of the
skeleton in chick limb buds devoid of dorsal ectoderm. Dev. Biol.
118, 233–246.
McIntosh, I., Bellus, G. A., and Jab, E. W. (2000). The pleiotropic
effects of fibroblast growth factor receptors in mammalian devel-
opment. Cell Struct. Funct. 25, 85–96.
Merino, R., Gan˜an, Y., Macias, D., Economides, A. N., Sampath,
K. T., and Hurle, J. M. (1998). Morphogenesis of digits in the
avian limb is controlled by FGFs, TGFbetas, and noggin through
BMP signaling. Dev. Biol. 200, 35–45.
Miura, T., and Shiota, K. (2000). TGFbeta2 acts as an “activator”
molecule in reaction-diffusion model and is involved in cell
sorting phenomenon in mouse limb micromass culture. Dev.
Dyn. 217, 241–249.
Mohammadi, M., McMahon, G., Sun, L., Tang, C., Hirth, P., Yeh,
B. K., Hubbard, S. R., and Schlessinger, J. (1997). Structures of the
tyrosine kinase domain of fibroblast growth factor receptor in
complex with inhibitors. Science 276, 955–960.
Momose, T., Tonegawa, A., Takeuchi, J., Ogawa, H., Umesono, K.,
and Yasuda, K. (1999). Efficient targeting of gene expression in
chick embryos by microelectroporation. Dev. Growth Differ. 41,
335–344.
Newman, S. A. (1996). Sticky fingers: Hox genes and cell adhesion
in vertebrate limb development. Bioessays 18, 171–174.
Newman, S. A., Pautou, M.-P., and Kieny, M. (1981). The distal
boundary of myogenic primordia in chimeric avian limb buds
and its relation to an accessible population of cartilage progenitor
cells. Dev. Biol. 84, 440–448.
Newman, S. A., and Tomasek, J. J. (1996). Morphogenesis of
connective tissues. In “Extracellular Matrix, Vol. 2: Molecular
Components and Interactions” (W. D. Comper, Ed.), pp. 335–369.
Harwood Academic Publishers, Amsterdam.
Oberlender, S. A., and Tuan, R. S. (1994). Expression and functional
involvement of N-cadherin in embryonic limb chondrogenesis.
Development 120, 177–187.
Oldridge, M., Zackai, E. H., McDonald-McGinn, D. M., Iseki, S.,
Morriss-Kay, G. M., Twigg, S. R., Johnson, D., Wall, S. A., Jiang,
W., Theda, C., Jabs, E. W., and Wilkie, A. O. (1999). De novo
alu-element insertions in FGFR2 identify a distinct pathological
basis for Apert syndrome. Am. J. Hum. Genet. 64, 446–461.
Pasquale, E. B. (1990). A distinctive family of embryonic protein-
tyrosine kinase receptors. Proc. Natl. Acad. Sci. USA 87, 5812–
5816.
Patstone, G., Pasquale, E. B., and Maher, P. A. (1993). Different
members of the fibroblast growth factor receptor family are
specific to distinct cell types in the developing chicken embryo.
Dev. Biol. 155, 107–123.
Paulsen, D. F., and Solursh, M. (1988). Microtiter micromass
cultures of limb-bud mesenchymal cells. In Vitro Cell. Dev. Biol.
24, 138–147.
Peters, K., Ornitz, D., Werner, S., and Williams, L. (1993). Unique
expression pattern of the FGF receptor 3 gene during mouse
organogenesis. Dev. Biol. 155, 423–430.
Peters, K. G., Werner, S., Chen, G., and Williams, L. T. (1992). Two
FGF receptor genes are differentially expressed in epithelial and
mesenchymal tissues during limb formation and organogenesis
in the mouse. Development 114, 233–243.
Saunders, J. W., Jr. (1996). Operations on limb buds of avian
embryos. In “Methods in Avian Embryology” (M. Bronner-
Fraser, Ed.), pp. 125–145. Academic Press, San Diego.
Savage, M. P., Hart, C. E., Riley, B. B., Sasse, J., Olwin, B. B., and
Fallon, J. F. (1993). Distribution of FGF-2 suggests it has a role in
chick limb bud growth. Dev. Dyn. 198, 159–170.
Shiang, R., Thompson, L. M., Zhu, Y. Z., Church, D. M., Fielder,
T. J., Bocian, M., Winokur, S. T., and Wasmuth, J. J. (1994).
Mutations in the transmembrane domain of FGFR3 cause the
most common genetic form of dwarfism, achondroplasia. Cell
78, 335–342.
Shubin, N. H. (1991). The implications of “the bauplan” for
development and evolution of the tetrapod limb. In “Develop-
mental Patterning of the Vertebrate Limb” (J. R. Hunchliffe, J. M.
Hurle, and D. Summerbell, Eds.), pp. 411–421. Plenum Press,
New York.
Solursh, M., and Reiter, R. S. (1988). Inhibitory and stimulatory
effects of limb ectoderm on in vitro chondrogenesis. J. Exp. Zool.
248, 147–154.
281Perinodular Inhibition of Limb Chondrogenesis
© 2002 Elsevier Science (USA). All rights reserved.
Solursh, M., Singley, C. T., and Reiter, R. S. (1981). The influence
of epithelia on cartilage and loose connective tissue formation by
limb mesenchyme cultures. Dev. Biol. 86, 471–482.
Summerton, J. (1999). Morpholino antisense oligomers: The case
for an RNase H-independent structural type. Biochim. Biophys.
Acta 1489, 141–158.
Szebenyi, G., Savage, M. P., Olwin, B. B., and Fallon, J. F. (1995).
Changes in the expression of fibroblast growth factor receptors
mark distinct stages of chondrogenesis in vitro and during chick
limb skeletal patterning. Dev. Dyn. 204, 446–456.
Tomasek, J. J., Mazurkiewicz, J. E., and Newman, S. A. (1982).
Nonuniform distribution of fibronectin during avian limb devel-
opment. Dev. Biol. 90, 118–126.
Upholt, W. B., and Olsen, B. R. (1991). The active genes of cartilage.
In “Cartilage: Molecular Aspects” (B. K. Hall and S. A. Newman,
Eds.), pp. 1–57. CRC Press, Boca Raton, FL.
Van Obberghen-Schilling, E., Roche, N. S., Flanders, K. C., Sporn,
M. B., and Roberts, A. (1988). Transforming growth factor beta-1
positively regulates its own expression in normal and trans-
formed cells. J. Biol. Chem. 263, 7741–7746.
Webster, M. K., and Donoghue, D. J. (1996). Constitutive activation
of fibroblast growth factor receptor 3 by the transmembrane
domain point mutation found in achondroplasia. EMBO J. 15,
520–527.
Widelitz, R. B., Jiang, T. X., Murray, B. A., and Chuong, C. M.
(1993). Adhesion molecules in skeletogenesis. II. Neural cell
adhesion molecules mediate precartilaginous mesenchymal con-
densations and enhance chondrogenesis. J. Cell. Physiol. 156,
399–411.
Wilkie, A. O., Slaney, S. F., Oldridge, M., Poole, M. D., Ashworth,
G. J., Hockley, A. D., Hayward, R. D., David, D. J., Pulleyn, L. J.,
Rutland, P., et al. (1995). Apert syndrome results from localized
mutations of FGFR2 and is allelic with Crouzon syndrome. Nat.
Genet. 9, 165–172.
Xu, X., Weinstein, M., Li, C., and Deng, C. (1999). Fibroblast
growth factor receptors (FGFRs) and their roles in limb develop-
ment. Cell Tissue Res. 296, 33–43.
Yonei-Tamura, S., Endo, T., Yajima, H., Ohuchi, H., Ide, H., and
Tamura, K. (1999). FGF7 and FGF10 directly induce the apical
ectodermal ridge in chick embryos. Dev. Biol. 211, 133–143.
Yu, K., Herr, A. B., Waksman, G., and Ornitz, D. M. (2000). Loss of
fibroblast growth factor receptor 2 ligand-binding specificity in
Apert syndrome. Proc. Natl. Acad. Sci. USA 97, 14536–14541.
Yu, K., and Ornitz, D. M. (2001). Uncoupling fibroblast growth
factor receptor 2 ligand binding specificity leads to Apert
syndrome-like phenotypes. Proc. Natl. Acad. Sci. USA 98, 3641–
3643.
Received for publication December 10, 2001
Revised May 13, 2002
Accepted June 19, 2002
Published online August 13, 2002
282 Moftah et al.
© 2002 Elsevier Science (USA). All rights reserved.
